IP Library Granted Patent US 10,783,636
Granted Patent B2
US 10,783,636 · App. 15/855,587 · Granted Sep 22, 2020

Methods and systems for characterizing tissue of a subject

Inventors: Lina Gurevich (Vancouver, CA); Jorgen Walle-Jensen (Vancouver, CA)
Assignee: Stryker European Operations Limited
G06T7/0016A61B5/0071A61B5/445G16H50/50A61B6/486A61B6/507A61B6/5217A61B2576/02G06T2207/10064G06T2207/30088G06T2207/30096G06T2207/30104G06T2210/41G06T2211/404
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,783,636
App. No.
15/855,587
Granted
Sep 22, 2020
Kind
B2
Abstract

Methods and systems for characterizing tissue of a subject are disclosed. The method includes receiving a time series of fluorescence images of the tissue of the subject wherein the images define a plurality of calculation regions, generating a plurality of time-intensity curves for the plurality of calculation regions, creating a set of parameter values for each calculation region, generating a total rank value for each calculation region by comparing the sets of parameter values, and converting the total rank value into a ranking map image. Also disclosed are methods and systems for characterizing a wound in tissue by generating a wound index value.

Claims (37)

1. A system for characterizing tissue of a subject, comprising:

one or more processors; and

memory having instructions stored thereon, the instructions, when executed by the one or more processors, cause the system to:

receive a time series of fluorescence images of the tissue of the subject, wherein the images define a plurality of calculation regions;

generate a plurality of time-intensity curves for the plurality of calculation regions;

generate, based on the plurality of time-intensity curves for the plurality of calculation regions, a ranking map image representing the plurality of calculation regions, wherein the ranking map image comprises at least one spatial dimension, and wherein the at least one spatial dimension comprises a horizontal spatial dimension and a vertical spatial dimension.

2. The system of claim 1 , wherein generating the ranking map image comprises:

creating a plurality of sets of parameter values for the plurality of calculation regions, wherein the parameter values approximate at least a portion of the time-intensity curve; and

generating the ranking map based on the set of parameter values for each calculation region.

3. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is related to time properties of the time-intensity curve, magnitude of intensity changes in the time-intensity curve, a coefficient relating to a polynomial characterization of the time-intensity curve, or a combination thereof.

4. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is for a parameter type comprising: (i) duration of a region of increasing intensity of the time-intensity curve, (ii) duration of a region of high intensity of the time-intensity curve, (iii) duration of a region of a plateau of the time-intensity curve, (iv) duration of a region of decreasing intensity of the time-intensity curve, or (v) a combination thereof.

5. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is for a parameter type comprising: (i) duration of a perfusion onset phase of the time-intensity curve, (ii) duration of an arterial phase of the time-intensity curve, (iii) duration of a micro-vascular phase of the time-intensity curve, (iv) duration of a venous phase of the time-intensity curve, or (v) a combination thereof.

6. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is for a parameter type comprising: (i) time to the onset of increasing fluorescence intensity, (ii) time for rapid or most rapid fluorescence intensity increase, (iii) time for rapid or most rapid fluorescence intensity decrease, (iv) rate of change in fluorescence intensity for any of the above-described regions of the time-intensity curve, or (v) a combination thereof.

7. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is for a parameter type comprising: (i) intensity change within a region of increasing intensity of the time-intensity curve, (ii) intensity change within a region of high intensity of the time-intensity curve, (iii) intensity change within a region of decreasing intensity of the time-intensity curve, or (iv) a combination thereof.

8. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is for a parameter type comprising: (i) intensity change during a perfusion onset phase of the time-intensity curve, (ii) intensity change during an arterial phase of the time-intensity curve, (iii) intensity change during a micro-vascular phase of the time-intensity curve, (iv) intensity change during a venous phase of the time-intensity curve, or a combination thereof.

9. The system of claim 2 , wherein at least one parameter value in the plurality of sets of parameter values is for a parameter type comprising: (i) intensity change during a period of rapid or most rapid fluorescence intensity increase, and (ii) intensity change during a period of rapid or most rapid fluorescence intensity decrease.

10. The system of claim 2 , wherein generating the ranking map image further comprises:

generating a total rank value for each calculation region by comparing the plurality of sets of parameter values for the plurality of calculation regions; and

converting the total rank values for the calculation regions into the ranking map image.

11. The system of claim 10 , wherein each parameter value is a value for a parameter type, and wherein comparing the plurality of sets of parameter values comprises generating a set of numeric ranks for the parameter types for each calculation region.

12. The system of claim 11 , wherein generating a total rank value for each calculation region comprises summing the set of numeric ranks for each calculation region.

13. The system of claim 11 , wherein generating a total rank value for each calculation region comprises mapping the set of numeric metrics for each calculation region with a hash function.

14. The system of claim 13 , wherein the hash function comprises a cyclic redundancy check or a pairing function.

15. The system of claim 10 , wherein converting the total rank values into the ranking map image comprises correlating each total rank value to an intensity value.

16. The system of claim 10 , wherein converting the total rank values into the ranking map image comprises correlating each total rank value to (i) an intensity value or (ii) a grayscale or color display value.

17. The system of claim 1 , wherein at least one calculation region is defined by one pixel or one voxel.

18. The system of claim 1 , wherein the instructions cause the system to superimpose the ranking map image on an anatomical image of the tissue on the display.

19. The system of claim 1 , further comprising a display, wherein the instructions cause the system to display the ranking map image on the display.

20. The system of claim 1 , further comprising a light source configured to provide an excitation light to induce fluorescence emission from a fluorescence imaging agent in the tissue.

21. The system of claim 1 , further comprising an image acquisition assembly that generates the time series of fluorescence images based on fluorescence emission from a fluorescence imaging agent in the tissue.

22. The system of claim 1 , wherein receiving a time series of fluorescence images comprises capturing transit of a bolus of a fluorescence imaging agent moving through the tissue.

23. The system of claim 22 , wherein the fluorescence imaging agent comprises indocyanine green, fluorescein isothiocyanate, rhodamine, phycoerythrin, phycocyanin, allophycocyanin, ophthaldehyde, fluorescamine, rose Bengal, trypan blue, fluoro-gold, green fluorescence protein, a flavin, methylene blue, porphysomes, cyanine dye, IRDDye800CW, CLR 1502 combined with a targeting ligand, OTL38 combined with a targeting ligand, or a combination thereof.

24. A method for use in medical imaging for characterizing tissue of a subject, the method comprising:

at a computer system including one or more processors and memory:

receiving a time series of fluorescence images of the tissue of the subject, wherein the images define a plurality of calculation regions;

generating a plurality of time-intensity curves for the plurality of calculation regions;

generating, based on the plurality of time-intensity curves for the plurality of calculation regions, a ranking map image representing the plurality of calculation regions, wherein the ranking map image comprises at least one spatial dimension, and wherein the at least one spatial dimension comprises a horizontal spatial dimension and a vertical spatial dimension.

Assignments (13)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2018
From: GUREVICH, LINA; WALLE-JENSEN, JORGEN
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 047292/0542 →
MERGER AND CHANGE OF NAME Recorded Oct 24, 2018
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 047301/0422 →
Continuity (4)
Continuation 15013945 · Feb 2, 2016
Provisional Application 62110609 · Feb 2, 2015
Provisional Application 62174225 · Jun 11, 2015
Related Publication 20180158187A1 · Jun 7, 2018
Cited By (3)
US 12,318,179 US 12,518,390 US 12,561,402